Pulse Biosciences, which is developing pulsed electric field technology to treat solid tumors, last week filed for an initial public offering worth $20 million. Burlingame, Calif.-based Pulse said it plans to float 5 million shares at $4 apiece, for a fully diluted valuation of $51 million. The company is developing “nano-pulse electro-signaling,” in which extremely […]
Oncology
Seno Medical touts data from Imagio breast cancer pilot study
Seno Medical Instruments on Monday released data from the pilot study portion of its Pioneer pivotal study examining its Imagio opto-acoustic tool designed to diagnose breast cancer. The company said data from the trial showed Imagio system improved physicians’ ability to classify benign breast masses when compared to traditional ultrasounds methods. Data from the 100-patient […]
Galil Medical kills $11m Perseon bid
Galil Medical spiked its $11 million tender offer for Perseon Medical (NSDQ:PRSN) and its MicroThermX microwave ablation device, after failing to gather enough shares despite extending the deadline. The deal, announced in October, called for Arden Hills, Minn.- and Yokneam, Israel-based Galil to pay $1 per share plus 2¢ per warrant for Perseon, formerly known as BSD Medical. Shareholders had tendered […]
Can Sirtex turn cancer into a chronic disease?
Big things sometimes come in small packages. For Sirtex Medical, big things come in a really small package. The Australian medical device company’s flagship product – SIR-Spheres® Y-90 resin microspheres – is made up of 30 million to 60 million microspheres about the size of a grain of sand, which are injected into the hepatic artery and […]
NovoCure touts JAMA publication of Optune trial data
NovoCure (NSDQ:NVCR) said today data from the pivotal phase 3 trial of its Optune device, in combination with standard-of-care temozolomide, for treating newly diagnosed glioblastoma has been published in the Journal of the American Medical Association. The results from the EF-14 trial reported that Optune along with temozolomide significantly extended progression-free survival and overall survival compared […]
Philips outsources mammogram electronics assembly to Note
Royal Philips (NYSE:PHG) inked an outsourced assembly deal with Northern European manufacturer NOTE to work with its Mammography Solutions division. The move was made as part of a re-organization of Philips operations in Solna, Sweden, according to NOTE. The outsourcing will utilize NOTE’s assembly capabilities, including complex assembly in a clean room environment. “We went […]
BTG wins FDA 510(k) for radiopaque beads, touts PneumRx coil study
BTG said today it won FDA 510(k) clearance for its LC Bead Lumi radiopaque embolic beads designed for embolization of hypervascular tumors and arteriovenous malformations and touted results from the Renew study of its PneumRx endobronchial coil implant. The Lumi was designed with radiopacity tech that allows for real-time tracking of bead location during embolization procedures, London-based BTG […]
Novocure touts preliminary data on tumor treating fields
NovoCure (NSDQ:NVCR) said yesterday that a retrospective analysis of its Tumor Treating Fields therapy showed it safe in adult glioblastoma patients with implanted non-programmable shunts. The FDA removed a pre-existing contraindication in October based on the safety data that contraindicated the therapy for patients with non-programmable shunts, Novocure said. The data was presented last month at […]
Surefire Medical raises $15m in Series C
Direct-to-tumor delivery system developer Surefire Medical said yesterday it brought in $15 million in a Series C round to support the global launch of its Surefire Precision device designed to treat primary liver cancer. The round was led by Tullis Health Investors, and joined by KMG Capital Partners, Partisan Management Group, MCG partners, High Country […]
Galil Medical extends deadline for $11m Perseon buy
Galil Medical said today that it’s extending the deadline on its $11 million tender offer for Perseon Medical (NSDQ:PRSN) and its MicroThermX microwave ablation device. Arden Hills, Minn.- and Yokneam, Isrel-based Galil said it moved the deadline from Dec. 11 to Dec. 21 “to allow additional time for the satisfaction of the financing condition.” CEO Marty Emerson said during a conference […]
How Exact Sciences built a DNA screening test for colorectal cancer
In a seemingly endless war on cancer, the best weapon remains early detection, according to Graham Lidgard, senior vice president of R&D at Exact Sciences Corp. For Lidgard, and the rest of the team at the Madison, Wisc.-based molecular diagnostics maker, the battlefield is colorectal cancer, 1 of the most common, and deadliest, cancers in […]